How new technologies are reshaping IP and deal terms in life sciences transactions

How new technologies are reshaping IP and deal terms in life sciences transactions

June 26, 2024, IAM

Complex IP licensing and collaboration agreements underpin the transactions that are crucial to pharmaceutical innovation. To ensure the long-term success of these strategic alliances, IP licensing lawyers must look into their crystal balls to identify key opportunities and risks, and seek to draft a framework that precisely allocates the IP rights but also embeds sufficient flexibility.